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Abstract: Background: This study investigated the effects of a prior individualized training program (TP) on the response 
to acute oxygen supply during exercise in chronic obstructive pulmonary disease (COPD) patients showing exercise-
induced desaturation. 
Methods: Twenty-two COPD patients (mean [SD] FEV1 = 52.1 [3]% predicted) who desaturated on exercise participated 
in a TP. Exercise tolerance while breathing compressed air or oxygen was assessed using a walking test (WT) before and 
after TP. Oxygen flow was individualized. 
Results: Before TP, acute oxygen supply improved mean exercise tolerance. But this response was heterogeneous as only 
8 patients increased their walking distance with oxygen. TP improved exercise tolerance in the entire population. How-
ever, a greater affect of oxygen administration during exercise was not observed after TP. The response to oxygen again 
showed great disparity as only 6 patients increased their walking distance with oxygen after TP. 
Conclusion: The response to oxygen supply during exercise varied among COPD patients. Moreover, despite the clinical 
benefits of TP, no cumulative effect of TP and oxygen supply was observed during exercise performance. 
Keywords: COPD, training program, oxygen, exercise. 
INTRODUCTION 
  Exercise-induced desaturation is well reported in patients 
with chronic obstructive pulmonary disease (COPD) [1]. 
Indeed, some COPD patients do not exhibit clinical resting 
hypoxemia, i.e. an arterial oxygen pressure (PaO2) less than 
55 mmHg, but they do show significant exercise-induced 
desaturation; these patients have been termed “desaturators” 
[2]. The six-minute walking test (WT) [1], a reliable clinical 
test to explore exercise tolerance in COPD patients, easily 
detects this desaturation. To correct this desaturation, oxygen 
is prescribed for desaturator patients to adjust the O2 satura-
tion (SpO2) above 90% during exercise and especially the 
exercise included in rehabilitation programs. Recently, Brad-
ley et al. [3] reviewed the evidence from single-assessment 
studies that this ambulatory O2 improves exercise perform-
ance in COPD patients but noted that the magnitude of im-
provement is unclear. The reports on the short-term O2 bene-
fits to these patients during exertion are indeed conflicting; 
some of the studies mentioned in Bradley’s review reported 
an increase in exercise performance [4-9], whereas others did 
not [10, 11]. Moreover, the values of the variables investi-
gated to assess the responses to O2 show great heterogeneity, 
which could lead to an average benefit that lacks signifi-
cance. In fact, it may be that in some COPD patients O2 is 
available to the exercising muscles (because SpO2 is cor-
rected) but is not used, suggesting that the peripheral mus-
cles of these patients are unsuitable for O2 use. 
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  Differences in exercise testing protocols, the prescribed 
flow, and/or disease severity have probably contributed to 
these divergent results [3]. For example, all the studies that 
reported a benefit from O2 used an O2 flow that was not in-
dividualized in relation to the O2 desaturation but was in-
stead predetermined. As we know that the O2 supply has a 
dose-response effect [9], this methodology seems not well 
adapted and may be far from rehabilitation reality. Moreo-
ver, in all the studies that examined the short-term benefits 
of O2 in COPD, no data were given on the training status of 
the desaturator subjects. It has been suggested that the exer-
cise-induced desaturation observed during a WT could be 
linked to muscle characteristics [1]. It is also well known 
that training can act on these muscle characteristics to im-
prove muscle function [12], with not only increases in aero-
bic enzymes and the capillary density of leg muscles [13], 
but also a changed breathing pattern with higher tidal vol-
ume and lower breathing frequency [14, 15]. As a conse-
quence, after TP, utilization of oxygen by COPD muscle 
should be more efficient and exercise performance increased. 
  This study thus tests the hypothesis that prior individual-
ized training in desaturator COPD patients will increase 
acute O2 supply effects on the exercise performance. 
MATERIAL AND METHODS 
Population 
  Twenty-two patients with mild to severe COPD as de-
fined by the Global Initiative for Chronic Obstructive Lung 
Disease guidelines [16] were recruited from an inpatient 
clinic before TP. All were desaturators as they presented 
significant O2 desaturation during WT, i.e. a fall in SpO2 of 
at least 4% over 3 minutes [1]. In addition, SpO2 had to be 30    The Open Respiratory Medicine Journal, 2008, Volume 2  Delample et al. 
lower than 90% to be qualified for acute O2 supply, i.e. am-
bulatory oxygen therapy. All patients were stable at the time 
of the study and no one was treated by long-term oxygen 
therapy or suffered from clinical cardiovascular, neurologi-
cal, or any other disease that might have contributed to 
dyspnoea or exercise limitation. The protocol was explained 
to each subject and all gave written informed consent. 
Initial Assessments 
  All patients underwent pulmonary function testing in-
cluding spirometry and lung volumes determined by 
plethysmography (V6200 Autobox; Sensormedics; Yorba 
Linda, CA, USA). Measurements of resting arterial blood 
gas levels while the patients breathed room air were obtained 
during a period of clinical stability and quantified with a 
blood gas analyser (pHOx Plus L, Nova Biomedical, 
Waltham, MA, USA). 
  All patients performed a cardiopulmonary exercise test 
(CPET) on an electrically-braked cycle ergometer (Ergomet-
rics 900; Ergoline; Bitz, Germany) following the individual-
ized protocol usually used in our laboratory. On-line calcula-
tions of whole-body oxygen consumption (VO2) were aver-
aged sequentially over 15-s intervals and displayed on a 
screen monitor to observe the progress of the test. Heart rate 
(HR) was measured continuously throughout the test by 12-
lead electrocardiography. The ventilatory threshold was de-
termined using the ventilatory equivalents of O2 and CO2 
method [17]. 
6-Minute Walking Test (WT) 
  The WT was performed around a perimeter of 31.5 m. 
Each subject performed two tests to allow the observation of 
any variability due to “learning”, with a rest of approxi-
mately 1 hour between tests. The second test was performed 
only if SpO2 and HR were identical to the values before the 
first WT. Patients were asked to walk at their own maximal 
rate and we retained the greater distance of the two tests. 
They were asked to cover as much ground as possible in 6 
minutes while maintaining a steady rate without running. No 
encouragement was given, and they were informed each 
minute of the remaining time. The patients were allowed to 
stop, but they could start again, if possible, within the allo-
cated 6 minutes. Arterial oxygen saturation (SpO2) and HR 
were monitored throughout the walk every minute using a 
pulse oximeter (Nonin 8500 M; Nonin Medical, Inc., Min-
neapolis, MN, USA). The patients were asked to indicate 
their level of breathlessness using a visual analogue scale 
before and immediately after each walk. 
Determination of O2 Flow 
  As there is no official consensus to individualize O2 flow 
supply according to O2 desaturation during the WT, we used 
the methodology of our clinic. This methodology has been 
used for several years and provides good re-saturation with 
SpO2 equal to or above 90%. When the patient exhibits SpO2 
between 90 and 85%, an O2 flow of 2 litres is given. When 84 
 SpO2  80%, O2 flow amounts to 4 litres. For SpO2 < 80%, 
O2 flow is 5 litres. O2 flow was via cylinder and nasal specs. 
Training Program (TP) 
  All patients participated in an in-patient training program 
for 4 weeks. The whole-body exercise training included sta-
tionary cycling, walking, swimming, and team sports. The 
exercise intensity was individualized according to target 
heart rate, i.e. the heart rate at the ventilatory threshold (VT) 
determined during CPET. This intensity was continuously 
monitored with a cardiofrequency meter and maintained 
throughout all exercise. The desaturator COPD patients did 
not always exhibit O2 desaturation during TP and ambulatory 
O2 was only used when necessary. For most of the program, 
in fact, they did not receive O2. Training sessions were held 
6 days per week and lasted 45 minutes on average. Training 
volume per week was 15.1 ± 1.2 h on average and divided in 
four sessions of stationary cycling (45 minutes per session), 
three sessions of swimming and team sports (45 minutes per 
session) and 4 sessions of walking (one or two hours per 
session). All sessions were supervised by a physiotherapist. 
Protocol 
  Initial assessments were made on admission to the clinic. 
One to three days after CPET, all patients performed 2 WTs 
on the same day. The first test (basal WT [BWT]) was per-
formed while they breathed room air. The second test (AIR-
WT) was performed while they breathed compressed air. At 
least one day later the patients were tested during WT whilst 
breathing oxygen (O2-WT). The O2-WT was performed 
twice as it is well known that the best performance is gener-
ally obtained from the second test. Oxygen flow was ad-
justed in all patients to reach an SpO2 > 90%. Before each 
WT, they breathed the gas mixture for 15 minutes. Two in-
distinguishable cylinders located at the middle of the walk-
ing perimeter, one with compressed air and one with O2, 
were connected to a 15-m tube ending in a nasal cannula. 
The patients did not know which gas was added. This ex-
perimental protocol was conducted by the same investigator 
before and after TP with the same flow of O2 and com-
pressed air. 
Statistical Analysis 
  Results are expressed as mean ± SEM. For each variable 
of interest, a two-way analysis of variance (ANOVA) with 
repeated measures was performed. One way was assigned for 
training condition (before/after) and the other for O2 supply 
(without/with). When ANOVA detected a significant main 
effect, post-hoc comparisons were made using a Tukey test. 
The comparison between the oxygen responder group and 
the non-responder group was performed using an unpaired t 
test. Significant differences were declared when p<0.05. 
RESULTS 
Baseline Characteristics 
 Table  1 shows the baseline characteristics of all the pa-
tients. The patients present a marked limitation of their aero-
bic capacity (VO2max = 50.4 ± 3.4% predicted). They had 
moderate chronic obstruction (FEV1 = 52.1 ± 3% predicted) 
and mild resting hypoxemia (PaO2 = 67.4 ± 1.5 mmHg). All 
patients showed clinical desaturation with a mean fall in 
SpO2 equal to 12.1 ± 1.3% and SpO2 at the end of WT equal 
to 81.1 ± 1.5%. During the O2-WT, 6 patients required a 
flow of 2 L, 8 patients required 4 L, and 8 patients required 5 
L. O2 administration thus prevented critical desaturation in 
all subjects and no patient had their SpO2 level fall to < 90% 
(End O2-WT SaO2 = 90.9 ± 0.6%). Acute O2 Supply Responses During Exercise in Desaturator COPD Patients  The Open Respiratory Medicine Journal, 2008, Volume 2    31 
Table  1.  Anthropometric, Spirometric and Physiological 
Data of COPD Patients Before Training Program 
 
Variables Values 
Age (yr)  61.9 ± 1.9 
Female: Male  07: 15 
BMI (kg/m)  26.1 ± 0.9 
Peak VO2 (%predicted)  50.4 ± 3.4 
Maximal HR (bpm)  125 ± 7 
HR at ventilatory threshold (bpm)  115 ± 6 
FEV1 (% predicted)  52.1 ± 3 
FEV1/FVC (%)  55.7 ± 2.7 
PaO2 (mmHg)  67.4 ± 1.5 
AIR-WT distance (m)  458.2 ± 20 
Baseline dyspnoea  1.3 ± 0.3 
End AIR-WT dyspnoea  6.1 ± 0.6 
Definition of abbreviations: BMI = body mass index; FVC: forced vital capacity; HR: 
heart rate. Values are mean ± SEM. 
 
O2 Responses Before TP 
  Comparison of the distance walked during AIR-WT ver-
sus O2-WT showed a statistically significant effect of O2 on 
walking distance (Table 2, p<0.05) with no change in HR at 
the end of WT. This increase in walking distance was asso-
ciated with a significant effect of O2 on dyspnoea (p<0.05), 
which was 6% lower at the end of O2-WT than at the end of 
AIR-WT. No effect of O2 on HR at rest or at the end of WT 
was observed (Table 2). Nevertheless, high variability was 
noted in the O2 response. In line with the literature, we con-
sidered the patients who increased their walking distance by 
at least 10% while breathing oxygen to be oxygen respond-
ers (see Methodological considerations in the discussion). 
Thus, compared with AIR-WT, during O2-WT 14 patients 
showed no improvement in exercise tolerance and 8 patients 
increased their walking distance (18.2 ± 2.7%, i.e. 74 ± 10.8 
m on average) (Fig. 1). No basal parameter predicted the 
occurrence of O2 benefits during O2-WT. However, oxygen 
responders seemed to have greater disease severity than non-
responders (FEV1 = 46.8 ± 4.9% predicted vs 53.7 ± 3.5% 
predicted, respectively) as well as lower exercise tolerance 
(distance walked during AIR-WT before TP: 407.5 ± 27.5 m 
vs 487.2 ± 24.6% predicted, respectively; p<0.05). 
Effects of TP 
  Endurance capacity, measured as an increase in the dis-
tance walked during WT, improved significantly after 4 
weeks of training (458.2 ± 20 m vs 512.4 ± 20.3 m; p<0.05) 
for the entire population. The mean gain was 13.2% after 
training, or 54.5 ± 12.9 m. Dyspnoea at rest and at the end of 
WT was significantly decreased after TP (p<0.05). TP had 
no significant effect on HR at rest or at the end of WT (Table 
2). The benefits of TP on exercise tolerance were the same in 
oxygen responders and non-responders (distance walked by 
oxygen responders increased by 67.4 ± 29.5 m and by non-
responders, 46.6 ± 12.2 m). 
O2 Responses After TP 
  After TP, the same O2 flow allocated before TP was used. 
On average, O2 inhalation during WT increased the distance 
walked statistically but not clinically, compared with AIR-
WT (512.4 ± 20.3 m vs 538 ± 19.9 m, respectively; p<0.05). 
O2 significantly decreased dyspnoea at the end of O2-WT  
(-9.3% between dyspnoea at the end of AIR-WT and dysp-
noea at the end of O2-WT; p<0.05). Despite the greater dis-
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Fig. (1). Individual data on walk distance on six minute walk test (WT) after breathing compressed air or oxygen. 32    The Open Respiratory Medicine Journal, 2008, Volume 2  Delample et al. 
tances covered, HR was not modified by acute oxygen sup-
ply, before or after WT. 
  Individual responses to O2 supply varied greatly. After 
TP, when patients breathed O2 during WT, 6 increased their 
walking distance by > 10% (18.7%, i.e. 73.1 m on average) 
but 16 showed no improvement. When we compared data 
before and after TP, only 4 patients who were able to in-
crease their walking distance with O2 before TP had also 
improved their walking distance after TP. Thus, 4 patients 
who were oxygen responders before TP became non-
responders after TP. And 2 patients who were oxygen non-
responders before TP became responders after TP. Again, no 
baseline characteristic allowed us to predict either situation. 
Effect of Compressed Air on Walking Distance 
  Compressed air administration did not modify the results 
of the basal test in any patient. Walking distance during 
BWT was 415.4 ± 27 m and 419.5 ± 24.3 m, which corre-
sponds to a 1.5% difference. 
DISCUSSION 
  The main result of this study reported that, despite the 
clinical benefits of TP, a prior TP did not optimize the acute 
effect of O2 supply on desaturator COPD patients during a 
walking test. We also confirmed that the responses to O2 
supply of COPD patients show wide disparity during exer-
cise. 
Methodological Considerations 
  Choice of exercise. The 6-minute walking test has been 
validated for the detection of therapeutic improvements in 
exercise tolerance and dyspnoea. It thus has been widely 
used to show that O2 supply during exercise can improve 
tolerance [4, 5, 18]. Walking was reported to be associated 
with the lowest mean SpO2 value when saturation was meas-
ured during several daytime activities [19]. In addition, WT 
is more sensitive to desaturation than other tests like cardio-
pulmonary exercise testing on cycle ergometer [1], and it 
provokes breathlessness. It thus appears to be a functional 
test well adapted to evaluating patients in their own daily 
surroundings. 
 Protocol  for  O2 supply. Contrary to other studies which 
gave a pre-determined FIO2 to their patients during exercise, 
we individualized the O2 flow on the basis of the desatura-
tion observed at the end of AIR-WT. This ensured that each 
patient reached a SpO2  90%. The O2 supply protocol de-
scribed above is regularly used in our institution and per-
sonal observation confirms that this individualized protocol 
effectively prevents desaturation during exertion. In our 
study, all our patients kept their SpO2   90% during WT 
(SpO2 = 90.9 ± 0.7% at the end O2-WT). 
 Oxygen  response.  Studies on O2 supply and its benefits 
always present their results as averages. A few recent studies 
have focused on the heterogeneity of these results. However, 
none have determined the threshold above which the in-
crease in walking distance thanks to O2 supply is clinically 
significant. In the literature, the variability between two WTs 
is less than 10% in many chronic diseases [20-24]. Moreo-
ver, Eiser et al. [25] observed an 8% variability between the 
WTs of COPD patients. We thus assumed that a variation 
above 10% should not be considered as variability but as 
clinically significant modification. 
Results Discussion 
  Our study demonstrated that before TP O2 inhalation sig-
nificantly increased the exercise tolerance of desaturator 
COPD patients. Several studies [5, 8, 26] have described 
improvements in the dyspnoea index and exercise perform-
ance when O2 was administered only during exercise. Some 
[8, 26] also noted difficulties in predicting the response to 
O2. In our study, no basal or WT parameter (especially exer-
cise-induced desaturation) reliably predicted the response to 
O2 supply during exercise. Nevertheless, disease severity and 
exercise capacity before TP tended to be lower in the oxygen 
responders. On average, our patients presented moderate 
chronic airway limitation (FEV1 = 52.1 ± 3% predicted) and 
Fujimoto et al. showed that patients with moderate severity 
(FEV1 > 50% predicted) did not improve exercise capacity 
to the same extent as did patients with more severe disease, 
indicating that O2 supply during exercise might be useful 
only in patients with moderate to severe disease. Somfay   
et al. [9] demonstrated that O2 supply during exercise in-
duced dose-dependent improvement in endurance and symp-
tom perception in COPD patients. In our study, we used a 
low O2 flow, which was nevertheless individualized. It is 
Table 2.  Effects of Acute Oxygen Supplementation and Training Program (TP) on WT in COPD Patients 
 
Before TP   After TP 
Variables 
AIR O2 AIR    O2 
Distance (m)  458.2 ± 20  489.6 ± 19.6  512.4 ± 20.3*  537.9 ± 19.9* 
SpO2 at rest (%)  93.2 ± 0.6  96.9 ± 0.4  95 ± 0.8  97,1 ± 0.5 
SpO2 at the end of the test (%)  81.1 ± 1.5  90.9 ± 0.7  81.1 ± 1.4  91.3 ± 1 
Dyspnoea at rest   1.3 ± 0.3  0.9 ± 0.3  0.7 ± 0.3*  0.8 ± 0.3* 
Dyspnoea at the end of the test   6.1 ± 0.6  5.5 ± 0.6  5.6 ± 0.7*  4.7 ± 0.6* 
HR at rest (bpm)  92 ± 2.8  90.4 ± 2.5  89.8 ± 2.7  90.6 ± 2.8 
HR at the end of the test (bpm)  117.7 ± 3  115.1 ± 3.4  119.3 ± 2.7  117 ± 3.4 
Values are represented as mean ± SD. 
*: p<0.05 within group comparison before versus after rehabilitation. 
: p<0.05 comparison between O2-WT and the corresponding AIR-WT. Acute O2 Supply Responses During Exercise in Desaturator COPD Patients  The Open Respiratory Medicine Journal, 2008, Volume 2    33 
possible that in these conditions, the response to O2 during 
exercise is less remarkable and not so clinically significant. 
But in our case, we observed the real effects of acute O2 sup-
plementation as it is prescribed in medical institutions. 
  Most studies have reported a wide range of individual 
responses to O2, as did ours. It must be emphasized that the 
effects of hyperoxia are multifactorial and involve many 
integrated mechanisms. During O2 breathing in this study, 
the end O2-WT heart rate was similar to air-WT despite the 
greater distances covered by the patients. In addition, acute 
O2 supply significantly reduced perceived dyspnoea at the 
end of WT. Jolly et al. [7] suggested that cardiovascular 
limitation could be implicated in the response to O2 during 
exercise. Moreover, in addition to the diffusion limitation in 
the lung, a diffusion limitation at the level of the skeletal 
muscles may be present [27]. Supplemental O2 may thus fail 
to enhance muscle O2 utilization during exercise in COPD 
patients with peripheral muscle weakness [28]. One hypothe-
sis to explain our heterogeneous responses is thus that in 
hyperoxic conditions, the above-mentioned mechanisms are 
involved but to different degrees in each patient. 
  On average, the response to O2 supply during exercise 
was not modified by TP. Although we observed an effect of 
O2 after TP on walking distance and dyspnoea, the combina-
tion of prior TP and acute O2 supply during exercise had no 
cumulative effect on the exercise tolerance of COPD patients 
who present exercise-induced desaturation. TP was, how-
ever, efficient in increasing exercise tolerance. Indeed, after 
training, the distance walked during WT was statistically and 
clinically increased and dyspnoea was significantly de-
creased with a heart rate at the end of the WT similar to that 
before TP. These results confirm the beneficial effects of 
individualized training on exercise tolerance in COPD pa-
tients. Exercise training induces cardiovascular benefits 
(with a gain in spontaneous baroreflex sensitivity) [29] and 
pulmonary benefits. Casaburi et al. [12] demonstrated more 
efficient exercise breathing patterns and lower ventilation 
(with increase in tidal volume). TP also produces changes in 
skeletal muscles (increased oxidative metabolism activity 
and mean fibre area) [13, 30]. In summary, TP improves 
exercise tolerance by inducing central (cardiopulmonary) 
and peripheral (peripheral skeletal muscle) adaptations. The 
success of O2 supply is also likely to depend on its net effects 
on cardiopulmonary and peripheral muscle functions [31]. 
As no cumulative effect of TP plus acute O2 supplementation 
was seen, we can hypothesize that the training modalities of 
our TP led to central adaptations but could not be adjusted 
enough to induce peripheral adaptations. More resistance 
training in this TP would probably induce peripheral adapta-
tions more efficiently since little demand is placed on the 
cardiopulmonary system [32] during this type of exercise, 
making it well tolerated by COPD patients. But possibly we 
did not observe a greater response to O2 after TP because the 
effects of TP far exceeded the acute effects of O2. Many fac-
tors account for the absence of a cumulative effect of train-
ing and O2 supply during exercise. The contribution of exer-
cise-induced desaturation to exercise limitation is still uncer-
tain, and the mechanisms by which O2 affects exercise toler-
ance are complex. The present study confirmed previous 
reports that showed that the acute effects of O2, as well as the 
effects of training, do not correlate with lung function pa-
rameters or blood gas values at rest or during exercise [4, 33, 
34]. Furthermore, in the present study, the acute effects of O2 
did not predict the effects of training in individual subjects. 
Hence, patients with a poor response to O2 are not necessar-
ily poor candidates for training. These findings suggest that 
oxygen and training may influence exercise tolerance by 
different mechanisms. 
  In summary, this study confirmed the great heterogeneity 
in responses to O2 supply during exercise, with approxi-
mately 35% of our COPD patients improving their exercise 
tolerance. The training program did not modify this response 
to O2, suggesting that efficient O2 utilization does not depend 
on muscular and central benefits of TP. Moreover, basal pa-
rameters and exercise-desaturation do not seem to be reliable 
criteria for selecting those patients who will most benefit 
from O2 during activities. As the response to this therapy is 
unpredictable, every patient should be individually evalu-
ated. 
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